Stocks of Revolution Medicines Inc (NASDAQ:RVMD) traded higher last session on Wall Street, down -0.09% to $58.58.
RVMD stock price is now 13.99% away from the 50-day moving average and 41.01% away from the 200-day moving average. The market capitalization of the company currently stands at $9.85B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $46 to $62, Needham maintained Buy rating for Revolution Medicines Inc (NASDAQ: RVMD). On July 12, 2024, Barclays recently initiated its ‘Overweight’ rating on the stock quoting a target price of $52, while ‘Jefferies’ rates the stock as ‘Buy’
In other news, Cislini Jeff, General Counsel sold 2,554 shares of the company’s stock on Nov 15 ’24. The stock was sold for $140,811 at an average price of $55.13. Upon completion of the transaction, the General Counsel now directly owns 43,080 shares in the company, valued at $2.52 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 15 ’24, Officer JEFFREY TODD CISLINI bought 2,554 shares of the business’s stock. A total of $146,523 was incurred on buying the stock at an average price of $57.37. A total of 16.18% of the company’s stock is owned by insiders.
During the past 12 months, Revolution Medicines Inc has had a low of $20.98 and a high of $62.40. As of last week, the company has a debt-to-equity ratio of 0.06, a current ratio of 14.24, and a quick ratio of 14.24. The fifty day moving average price for RVMD is $51.1014 and a two-hundred day moving average price translates $41.39425 for the stock.
The latest earnings results from Revolution Medicines Inc (NASDAQ: RVMD) was released for 2024-09-30. The net profit margin was -76423.32% and return on equity was -47.18% for RVMD.
